Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 21, 2017
Source ID
10.1007/s10549-017-4201-0

Entities

People

  • Dmitry Malin
  • Elena Strekalova
  • Harisha Rajanala
  • Vincent L Cryns

Organizations

  • National Cancer Institute
  • The Breast Cancer Research Foundation
  • United States Department of Defense